REG - ConvaTec Group PLC - Result of AGM
RNS Number : 9695XConvaTec Group PLC07 May 2021ConvaTec Group Plc
Results of Annual General Meeting
Reading, United Kingdom 7 May 2021 - Poll Result
ConvaTec Group Plc ("ConvaTec") held its annual general meeting today ("AGM"). The results of the poll held in relation to the resolutions proposed at the AGM are set out below:
For
(see note 2)
Against
(see note 2)
Total Votes cast
% of ISC Voted
Number of Votes Withheld
(see note 3)
Resolution
No of shares
%
No of shares
%
1
Receive Annual Report and Accounts
1,744,608,352
99.96
777,616
0.04
1,745,385,968
87.08%
1,480,001
2
Approve the Directors' Remuneration Report
1,698,130,077
97.23
48,413,492
2.77
1,746,543,569
87.14%
322,400
3
Declare Final Dividend
1,740,839,314
99.66
5,915,934
0.34
1,746,755,248
87.15%
110,721
4
Re-elect John McAdam as a director
1,726,805,777
98.88
19,520,971
1.12
1,746,326,748
87.13%
539,221
5
Re-elect Karim Bitar as a director
1,745,847,330
99.95
907,151
0.05
1,746,754,481
87.15%
111,488
6
Re-elect Frank Schulkes as a director
1,739,573,569
99.59
7,176,168
0.41
1,746,749,737
87.15%
116,232
7
Re-elect Margaret Ewing as a director
1,735,171,507
99.34
11,573,127
0.66
1,746,744,634
87.15%
121,335
8
Re-elect Brian May as a director
1,726,852,048
98.86
19,898,392
1.14
1,746,750,440
87.15%
115,529
9
Re-elect Rick Anderson as a director
1,732,922,453
99.21
13,822,181
0.79
1,746,744,634
87.15%
121,335
10
Re-elect Regina Benjamin as a director
1,733,824,898
99.26
12,925,036
0.74
1,746,749,934
87.15%
116,035
11
Re-elect Sten Scheibye as a director
1,745,567,146
99.93
1,187,335
0.07
1,746,754,481
87.15%
111,488
12
Elect Heather Mason as a director
1,744,886,278
99.89
1,863,459
0.11
1,746,749,737
87.15%
116,232
13
Elect Constantin Coussios as a director
1,744,393,943
99.87
2,356,497
0.13
1,746,750,440
87.15%
115,529
14
Re-appoint Deloitte LLP as auditor
1,746,633,262
99.99
118,345
0.01
1,746,751,607
87.15%
114,362
15
Authorise the directors to determine the remuneration of the Company's auditor
1,746,753,488
100.00
433
0.00
1,746,753,921
87.15%
112,048
16
Authorise political donations and political expenditure
1,721,717,493
98.58
24,812,022
1.42
1,746,529,515
87.14%
336,454
17
Authorise allotment of shares
1,623,589,106
92.97
122,709,426
7.03
1,746,298,532
87.13%
567,437
18
Disapply pre-emption rights*
1,736,680,253
99.45
9,522,182
0.55
1,746,202,435
87.12%
663,534
19
Disapply pre-emption rights in connection with an acquisition or specified capital investment*
1,691,979,685
96.87
54,580,936
3.13
1,746,560,621
87.14%
305,348
20
Authorise purchase of own shares*
1,741,411,621
99.75
4,350,959
0.25
1,745,762,580
87.10%
1,103,389
21
Call general meetings on 14 days' notice*
1,657,330,730
94.88
89,418,003
5.12
1,746,748,733
87.15%
117,236
*Special Resolution
NOTES:
1. All resolutions were passed.
2. Votes "For" and "Against" are expressed as a percentage of votes received.
3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.
4. Total number of shares in issue at close of business on 5 May 2021 was 2,004,347,138 shares; 87.15% of voting capital was instructed.
5. Computershare acted as scrutineer of the poll on all resolutions.
In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business that were passed at the Meeting will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com
Enquiries
Analysts and Investors
Kate Postans, Vice President Investor Relations, ConvaTec +44 (0)7826 447 807
Media
Buchanan: Charles Ryland / Chris Lane +44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
# # #
END
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDRAGUBSORAOUVRAR
Recent news on ConvaTec
See all newsREG-Convatec Group PLC Convatec Group PLC: Director/ PDMR Shareholding
AnnouncementREG - ConvaTec Group PLC - Annual Results
AnnouncementREG - ConvaTec Group PLC - Trading Update for ten months to 31 October 2023
AnnouncementREG - ConvaTec Group PLC - Total Voting Rights
AnnouncementREG - ConvaTec Group PLC - Director/PDMR Shareholding
Announcement